Preços e notícias sobre o fundo mútuo Fidelity Advisor Biotechnology Fund - Class A (FBTAX): Google Finanças

Finanças

Página inicialFBTAX • Fundo Mútuo

Fidelity Advisor Biotechnology Fund - Class A

$ 37,40

30 de dez. · USD · MUTF · Exoneração de responsabilidade

Franklin Biotechnology Discovery Fund Class A

$ 165,07

FBDIX1,08%

Fidelity Select Health Care Portfolio

$ 28,48

FSPHX0,56%

ProFunds Biotechnology UltraSector Fund Investor Class

$ 67,12

BIPIX2,46%

Vanguard Health Care Fund Admiral Shares

$ 86,57

VGHAX0,24%

Janus Henderson Global Life Sciences Fund Class T

$ 80,68

JAGLX0,42%

Fidelity Advisor Blue Chip Growth Fund - Class A

$ 267,54

FBCCX0,082%

Janus Henderson Contrarian Fund Class D

$ 27,04

JACNX0,26%

Rydex NASDAQ-100® 2x Strategy Fund Class C

$ 457,43

RYCCX0,51%

Vanguard International Explorer Fund Investor Shares

$ 20,20

VINEX0,049%

ProFunds UltraNASDAQ-100 Fund Investor Class

$ 127,54

UOPIX0,50%

Último fechamento

$ 37,91

Retorno acumulado no ano

46,38%

Proporção de despesas

0,96%

Categoria

Healthcare Sector Equity

Classificação Morningstar

Ativos líquidos

801,77 mi USD

Rendimento

1,95%

Taxa de ingresso

5,75%

Data de lançamento

27 de dez. de 2000

Notícias sobre o mercado

The Globe and Mail

TSX records third day of losses as tech stocks fall

Yahoo! Finance Canada

Canada's TSX is expected to rise in 2026, possibly reaching as high as 35,200

S&P/TSX composite changes direction to a negative finish, U.S. markets also slide

AMAYA BIG SKY CAPITAL ANNOUNCES TSXV CONDITIONAL ACCEPTANCE AND FILING OF FILING STATEMENT FOR QUALIFYING TRANSACTION

S&P/TSX composite down more than 75 points, while US stock markets also lower

Investing.com Brasil - Finanças, Câmbio e Investimentos

Canadá - Ações fecharam o pregão em queda e o Índice S&P/TSX recuou 0,10%

Pesquisa

Limpar pesquisa

Fechar pesquisa

Google Apps

Menu principal